Costs were not reported as discounted. The cost implications of diagnosis, treatment, and terminal care were included in the analysis. Major quantities of resource use were analysed separately from the costs. The major sources of these quantities were the two studies which in turn served as sources for the effectiveness data of the study. However, it is worth noting that major resource data for the intervention (i.e. terminal care hospitalisation) were assumed to be similar to that for the chemotherapeutic option in the clinical study which provided the survival data associated with the comparator in the effectiveness study. Original cost data for 1984 and 1988 were inflated using the Canadian Consumer Price Index (by 41.1% and 20.1%, respectively) to obtain the final estimates in 1993 prices. Total costs were estimated using a model, which also gave Canadian estimates of the implications of a potential nation-wide intervention.